Project Grant HT94252310625

Award Date 7/15/23
Completion Date 7/14/25
Dollars Obligated $551K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and...
This federal Project Grant award, valued at $548,519.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Leland Stanford Junior University (Stanford University) to conduct research on targeting the RSK protein for the treatment of pediatric acute myeloid leukemia. The award period is from September 15, 2023, to September 14, 2026. As a leading research university, Stanford University has significant experience...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,225,171 to The Leland Stanford Junior University to conduct research on the early detection of kidney cancer using tumor-educated platelets. The performance period for this award runs from August 1, 2024 to July 31, 2028. As a leading private research institution, Stanford University will leverage its expertise in medicine, engineering, and...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $4,232,760.00 to The Leland Stanford Junior University (Stanford University) to advance cure rates for infantile acute lymphoblastic leukemia. The award period runs from June 1, 2025 to May 31, 2029. As a leading private research institution, Stanford University will leverage its expertise in medical research to conduct innovative and...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,795,499 project grant to The Leland Stanford Junior University, doing business as Stanford University, to conduct an evaluation of clinical responders with advanced triple-negative breast cancer from the KEYNOTE-890 study. The purpose of this 4-year project is to validate a published CXCR3 gene signature that may help identify patients likely to respond to certain cancer...
The Defense Health Agency awarded a $430,513 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Leland Stanford Junior University. The grant, with a performance period from March 1, 2025 to February 28, 2027, will fund research to understand how vascular endothelial cells regulate fibroblast functions in pancreatitis. This work aligns with the program's focus on transforming healthcare for military service members and the general public through...
This federal Formula Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $370,866.00 to The Leland Stanford Junior University to conduct research on "Uncovering Synthetically Lethal Genes in the Presence of Protein Folding Stress in Lung Cancer In Vivo". The grant, with a performance period from April 1, 2025 to March 31, 2026, supports advanced biomedical research initiatives focused on transforming healthcare...
This Project Grant award of $2,209,988.00 from the Defense Health Agency supports research by The Leland Stanford Junior University, doing business as Stanford University, to develop pharmacological approaches for protection and recovery from burn-associated inhalation injury. The research is funded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for service members and the public. Over the award period from...
The Department of the Army Medical Command awarded a $469,381 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Leland Stanford Junior University. The grant, with a performance period from April 15, 2025 to April 14, 2027, supports research to engineer cytotoxic lymphocytes to infiltrate ovarian cancer tumors via metabolite-sensing receptors. This work aims to transform healthcare for military service members and the general public...

This federal Project Grant award of $550,533 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Stanford University to develop a combination treatment of nitazoxanide and auranofin for anaplastic thyroid cancer. The goal of the 2-year project is to transform health care for Service Members and the American public through innovative and impactful research investigating medical solutions for the battlefield. Stanford University, a private research university, is conducting this biomedical research project with the award period running from July 15, 2023 to July 14, 2025.

Generated 3/26/24, 12:09 PM